Stanley Capital

Stanley Capital is a private equity investment firm based in London, established in 2019. The firm focuses on pursuing repeatable relative value and thematic investment strategies, primarily in the technology, healthcare, and sustainability sectors. Stanley Capital targets businesses with enterprise values ranging from $250 million to $2.5 billion, concentrating its investments across Europe. The firm is dedicated to identifying opportunities that align with its investment themes, particularly in technology and sustainability.

James Brooks

Founding Partner

Simon Cottle

Founding Partner

Patrick Hargutt

Founding Partner

1 past transactions

Noden Pharma

Acquisition in 2020
Noden Pharma is a global specialty pharmaceutical company dedicated to acquiring and marketing prescription medicines across various therapeutic areas. The company holds exclusive worldwide rights to manufacture and sell Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor used in the treatment of hypertension. By focusing on international markets, Noden Pharma aims to enhance the lives of patients through effective medical solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.